Best GLP-1 Provider for Teens (2026): 4 Safe Paths
Last verified: May 29, 2026 · Independent research · No clinic paid for placement
What we reviewed for this page
Current FDA drug labels, the FDA's statements on compounded GLP-1s, the American Academy of Pediatrics (AAP) 2023 obesity guideline, and the public terms of major online GLP-1 programs.
Affiliate disclosure
Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We may earn a commission when an adult (18+) reader starts certain programs through our links. We earn nothing from steering a minor anywhere — and we don't. The advice for teens here points to medical care, not a sale.
Not medical advice
This is education. Only a licensed clinician who examines your child can decide whether any medication is right for them.
The best GLP-1 provider for teens (ages 12–17) is almost always a pediatrician, a pediatric obesity medicine specialist, or a children's hospital weight-management clinic — not a standard adult telehealth app. Here's the honest reason: only two GLP-1s are FDA-approved for adolescent obesity (the Wegovy injection and Saxenda), most popular online GLP-1 programs only serve adults 18+, and compounded GLP-1s are not FDA-approved finished drugs.
What is the best GLP-1 provider for teens?
For a 12–17-year-old, the best GLP-1 provider is a pediatrician, a pediatric obesity medicine specialist, or a children's hospital weight clinic — not an adult telehealth brand.
Read nothing else? Read this table.
| Best starting point for a teen | Who it fits | Why it's here |
|---|---|---|
| Pediatrician → specialist referral | Most 12–17-year-olds | Your doctor can document BMI percentile, growth, and health history, then refer you on if needed. Best first step for almost everyone. |
| Children's hospital / teen weight clinic | Complex or higher-risk cases | Strongest team-based care for teens with prediabetes, PCOS, sleep apnea, or a history of disordered eating. |
| Adolescent-specific obesity telehealth clinic | Families with no local specialist | Can work — if it's licensed in your state, treats your child's age, involves a parent, and uses FDA-approved teen options. Verify before you trust it. |
| Adult GLP-1 telehealth apps (Ro, Sesame, etc.) | 18+ only | Built for adults. We confirmed several require you to be 18 or older. Not the route for a minor. |
What we actually verified (so you don't have to open 12 tabs)
Every claim below is pulled from a primary source and linked in Sources at the end.
- Wegovy injection (semaglutide) is FDA-approved for chronic weight management in kids 12 and older with obesity. Cleared for teens in December 2022.
- Saxenda (liraglutide) is FDA-approved for teens 12 and older with obesity and a body weight above 60 kg (about 132 lb). Cleared for adolescents in December 2020.
- The Wegovy pill is NOT approved for adolescents — only the injection is. The current label (revised February 2026) lists the tablets for adults only.
- Zepbound (tirzepatide) is adults 18+ only. Eli Lilly states safety and effectiveness in children have not been established.
- Foundayo (orforglipron), the GLP-1 pill approved April 1, 2026, is adults only. Its label says safety and effectiveness in children have not been established.
- The AAP says doctors should offer weight-loss medication to adolescents 12+ with obesity — but as an add-on to intensive lifestyle support, not a stand-alone fix.
- Compounded GLP-1s are not FDA-approved. Semaglutide and tirzepatide are no longer on the FDA shortage list, so pharmacies generally can't keep making copies except in limited, patient-specific cases.
- On March 3, 2026, the FDA sent warning letters to 30 telehealth companies for false or misleading claims about compounded GLP-1 products.
- Ro requires users to be 18 or older — and we confirmed the same for Sesame, Eden, MEDVi, and Yucca.
The map nobody else gives parents: our Teen GLP-1 Provider Safety Matrix
Most pages rank providers by price or speed. For a teen, those are the wrong yardsticks. The right ones are: Will they treat a minor? Do they use medicine that's actually approved for kids? Will they watch growth and nutrition? Is a parent in the loop?
| Care path | Treats minors? | FDA-approved teen meds | Watches growth + nutrition | Screens for ED risk | Parent involved | Helps with insurance |
|---|---|---|---|---|---|---|
| Pediatrician + specialist referral | Yes | Yes (Wegovy inj., Saxenda) | Yes | Yes | Yes | Often |
| Children's hospital / teen clinic | Yes | Yes | Yes (team-based) | Yes (often dietitian + behavioral health) | Yes | Usually |
| Adolescent obesity telehealth clinic | Sometimes | Should — confirm it | Should — confirm it | Should — confirm it | Should — confirm it | Sometimes |
| Adult GLP-1 telehealth app | No — 18+ | N/A for minors | N/A | N/A | No | Some (for adults) |
Our conclusion
For a minor, the "winner" isn't an online weight-loss brand. It's the pediatric medical path — your pediatrician first, a pediatric obesity specialist or children's hospital clinic if your doctor refers you. That's where the FDA-approved teen options, the growth monitoring, and the safety net actually live.
How we scored each path
| Criteria (weight) | Pediatric specialist / hospital | Pediatrician + referral | Adolescent telehealth clinic |
|---|---|---|---|
| Treats minors / clear age rules (25) | 25 | 25 | 20 |
| Uses FDA-approved teen medicine (25) | 25 | 20 | 20 |
| Pediatric / adolescent experience (20) | 20 | 18 | 16 |
| Insurance + prior-auth help (10) | 7 | 7 | 6 |
| Follow-up, nutrition, labs (10) | 10 | 9 | 8 |
| Compounded-drug caution (5) | 5 | 5 | 4 |
| Clear public policy (5) | 2 | 2 | 4 |
| Total | 94 | 86 | 78 |
Adult apps aren't scored for minors — they're 18+. Scores are our editorial judgment based on verified facts above, not a medical rating of any one clinic.
Adult provider age policies we checked — last verified May 29, 2026
| Provider | What its terms say about age | A route for a minor? |
|---|---|---|
| Ro | Users must be 18 or older | No — adult/18+ only |
| Sesame | Users must be 18+ (or the age of majority where higher) | No — adult/18+ only |
| Eden | Services intended for users 18+ (some services 21+) | No — adult/18+ only |
| MEDVi | Users must be at least 18 | No — adult/18+ only |
| Yucca Health | Users must be at least 18; dispenses compounded GLP-1s | No — adult/18+ only |
| SHED | Adult weight-loss program built around compounded GLP-1s; confirm current minimum age on its site | No — treat as 18+ for a minor |
Here's the part most "best provider" pages won't say out loud
We make money when adult readers choose certain online programs. So the most honest thing we can tell you is the thing that earns us nothing: for a 12–17-year-old, the best first move is a doctor, not a checkout page.
Ro does not treat minors — and neither do the other adult apps we checked. If a fast online prescription is what you were hoping for, we get it, and we won't pretend an adult program is right for your kid just to earn a click. We'd rather lose you here and keep your trust.
The good news: there is a clear path, it's safer than the shortcut, and it's not as slow or scary as it sounds. The move isn't to buy something online; it's to get your teen in front of the right clinician.
Find your teen's path (start here)
One question decides everything else: how old is your teen?
Under 12
Start with your pediatrician. GLP-1 weight-loss medicine generally isn't the standard approved path at this age. Ask about growth, nutrition, and whether a referral to a pediatric specialist makes sense.
12 to 17 (the heart of this guide)
Start with your pediatrician or a pediatric obesity specialist. Use the parent checklist below. Ask specifically about the Wegovy injection and Saxenda. Skip the adult apps and the compounded shortcuts.
18 or older
Your teen is a legal adult, so real online options open up. Jump to the "What if my teen is already 18?" section below for FDA-approved programs.
Can teens even get GLP-1 medication?
Some teens can — but only under real medical criteria and a clinician's care.
Current FDA approvals and the 2023 AAP guideline support certain weight-loss medicines for adolescents 12 and older with obesity. That does not mean every teen qualifies, and it does not mean an adult app is the place to get it.
The age lines that matter
- Under 12: GLP-1 weight-loss medicine generally isn't the standard approved path. Start with a pediatrician.
- 12–17: Medication may be considered when criteria are met — always alongside lifestyle support and follow-up.
- 18–19: Adult program rules apply, and FDA-approved online options become realistic.
"FDA-approved for teens" is not the same as "this app treats teens"
A medicine can be approved for a 12-year-old and the company that sells it online can still refuse anyone under 18. The medicine and the storefront have different rules. Keep them separate in your head and you'll stop hitting dead ends.
Which GLP-1 medications are FDA-approved for teens?
For teens, two GLP-1s carry FDA approval for obesity: the Wegovy injection and Saxenda. That's it.
| Medication | What it is | Approved for teens? | What parents should know |
|---|---|---|---|
| Wegovy injection | Semaglutide, once-weekly shot | Yes — ages 12+ with obesity | The main teen GLP-1 you'll hear about. Approved Dec 2022. |
| Saxenda | Liraglutide, daily shot | Yes — ages 12+ with obesity, over 60 kg / 132 lb | An older daily option. Approved for teens Dec 2020. A daily shot is less convenient than weekly. |
| Wegovy pill | Oral semaglutide | No | The pill isn't approved for adolescents. Only the injection is. Not interchangeable. |
| Zepbound | Tirzepatide, weekly shot | No — 18+ | Lilly says safety in kids isn't established. A teen study is underway, but it's adult-only today. |
| Foundayo | Orforglipron, daily pill | No — 18+ | Approved April 1, 2026, for adults. Pediatric studies are still required and ongoing. |
| Ozempic | Semaglutide for type 2 diabetes | Not the teen weight-loss answer | It's a diabetes drug. Don't think of it as "the teen weight-loss medicine." |
Why the Wegovy shot and the Wegovy pill aren't the same answer for a teen
People hear "Wegovy" and picture one product. For adolescents, only the injection is approved. The pill is for adults. If a provider offers your teen "Wegovy" as a pill, that's a red flag worth questioning. We break down the differences in our guide to the Wegovy pill vs. the Wegovy injection.
Does my teen actually qualify?
A teen may qualify for a GLP-1 evaluation when they're at least 12 and have obesity by pediatric BMI standards — usually a BMI at or above the 95th percentile for their age and sex. But qualifying isn't just a number. Clinicians also look at health conditions, growth, nutrition, mental health, and whether real lifestyle support is in place first.
In STEP TEENS — the trial behind Wegovy's teen approval — 201 adolescents (average age about 15) lost roughly 16% of their BMI over 68 weeks with semaglutide plus lifestyle changes, versus a slight increase (about 0.6%) for those on placebo plus lifestyle changes. Those teens were carefully selected and closely monitored.
BMI percentile, not adult BMI
Teens don't use the adult "BMI 30" cutoff. They use percentiles that account for age and sex, based on CDC growth charts. Your pediatrician reads this correctly. Don't try to eyeball it.
Conditions that make the conversation more urgent
Prediabetes or type 2 diabetes risk, PCOS, high cholesterol, high blood pressure, sleep apnea, fatty liver disease, joint or mobility problems, or severe obesity.
When the honest answer is "not yet" — or "not this way"
A good provider will sometimes slow down, and that's a sign they're doing it right. Reasons to pause or pick a different path include: a child under 12, weight loss wanted only for looks, any sign of an eating disorder, pregnancy or planning pregnancy, serious stomach disease, a history of pancreatitis, a personal or family history of a rare thyroid cancer (medullary thyroid carcinoma) or the condition MEN2, or unstable mental health. These are examples a clinician screens for — not a full list.
Can teens get GLP-1s online — and which providers treat minors?
A few adolescent-focused clinics may offer telehealth for teens, but most mainstream adult GLP-1 apps should be assumed off-limits for minors.
What good online care for a teen looks like
- Clearly states it treats minors in your child's age range
- Licensed in your state
- Requires a parent or guardian in the process
- Uses FDA-approved adolescent options when medicine is appropriate
- Screens for eating disorders and mental-health risk
- Orders labs and tracks vital signs
- Gives clear instructions for side effects and when to call
- Helps with insurance paperwork
- Never funnels a minor into an adult compounded program
Red flags that should stop you cold
- No clear age policy
- No parent/guardian step
- Uses compounded GLP-1 as the default for a kid
- No pediatric experience on the care team
- No follow-up schedule
- Promises the medicine before a real medical review
- Throws around "Ozempic for teens" loosely
- Won't tell you which pharmacy fills the prescription
Should we avoid compounded GLP-1s for our teen?
Yes — be very cautious about compounded GLP-1s for a minor.
A "compounded" drug is one a pharmacy mixes to order; it is not an FDA-approved finished product. The FDA says unapproved GLP-1 versions can be risky because they don't go through FDA review for safety, effectiveness, or quality before they're sold. For a growing teen, that uncertainty matters more, not less.
| Type | What it means for your teen |
|---|---|
| FDA-approved brand drug (like Wegovy) | Reviewed and approved by the FDA, with tested labeling. The safe baseline. |
| Compounded drug | Prepared by a compounding pharmacy under specific rules. Not FDA-approved as a finished product. "Contains semaglutide" is NOT the same as "FDA-approved Wegovy." |
Why the rules just changed
During the GLP-1 shortage, pharmacies could make copies of semaglutide and tirzepatide. That shortage is over — tirzepatide came off the FDA list in late 2024 and semaglutide in February 2025 — so compounders generally can't keep making copies of FDA-approved GLP-1s except in limited, patient-specific situations. On March 3, 2026 the FDA sent warning letters to 30 telehealth companies for misleading claims.
Compounded GLP-1 should never be sold as the easy shortcut around cost or access for a child.
What should a good provider check before prescribing?
A good teen GLP-1 provider does far more than weigh your child.
They should review BMI percentile, full medical history, current medicines, growth and puberty, nutrition, mental health and eating-disorder risk, family support, labs when needed, insurance requirements, and a real follow-up plan. If a provider skips most of this, that tells you something.
Your parent checklist — save this before the visit
Have ready before the appointment:
- Current height and weight, plus growth trend if you have it
- Any BMI percentile your doctor has noted
- Past weight-management attempts
- Family medical history
- All medicines and supplements your teen takes
- History of PCOS, prediabetes, cholesterol, blood pressure, or sleep apnea
- Mental-health history
- Any eating-disorder history or concerns — say this out loud
- Eating habits (especially protein and calcium)
- Insurance card and prescription benefits
- Preferred pharmacy
Ask the provider:
- Do you treat adolescents, or only adults?
- Which GLP-1 medicines do you prescribe for minors?
- Do you only use FDA-approved adolescent options?
- How do you monitor growth, nutrition, and labs?
- How do you screen for disordered eating?
- How often are follow-ups?
- What symptoms mean we should call you right away?
- Who handles insurance prior authorization?
- What happens if our insurance says no?
- What's the plan if we stop the medicine?
What are the risks and dealbreakers for teens?
GLP-1 treatment can help some adolescents, but it is not a casual shortcut.
Common things to expect a doctor to discuss
Nausea, vomiting, constipation, diarrhea, lower appetite, dehydration risk, trouble getting enough protein or calcium, tiredness, and injection-site comfort.
Gallbladder risk is higher in teens than adults
This is the kind of specific number a parent deserves. In the pediatric Wegovy trial, gallstones (cholelithiasis) were reported in 3.8% of teens on Wegovy versus 0% on placebo, and gallbladder inflammation (cholecystitis) in 0.8% versus 0%. Those rates were higher in teens than in adults on the same medicine. Rapid weight loss can raise gallbladder risk on its own — which is one more reason a teen needs monitoring, not a hands-off prescription.
Serious things to screen for
A personal or family history of medullary thyroid cancer or MEN2, past pancreatitis, gallbladder disease, severe stomach disease, an active eating disorder, unstable depression, pregnancy or planning it, and other diabetes medicines that could push blood sugar too low.
Why growth and nutrition make teen care different
A teen is still building bones and a body. Care has to protect growth, protein, and calcium — not just shrink a number on a scale. The AAP is clear that obesity care for kids should be family-centered and non-stigmatizing, and that clinicians should screen for disordered eating. That screening only happens on the supervised path.
How much does GLP-1 treatment for a teen cost, and will insurance cover it?
Teen GLP-1 cost depends mostly on the medicine, your insurance, prior authorization, pharmacy pricing, and which kind of provider you use.
Do not pick a provider based on the lowest advertised adult cash price — first confirm they treat minors and use an appropriate medicine.
| Cost piece | What to check |
|---|---|
| Clinical visit | Pediatrician copay, specialist fee, clinic fee, or a cash telehealth fee |
| Labs and vitals | Whether insurance covers them |
| Medication | Brand price, insurance coverage, manufacturer savings programs, pharmacy supply |
| Prior authorization | Who files the paperwork and appeals a denial |
| Follow-up | Monthly or quarterly visits, dietitian support |
| Supplies | Needles, sharps container, shipping |
What insurers usually ask for
- BMI percentile (at or above the 95th percentile for age and sex)
- A documented diagnosis and any related conditions (prediabetes, sleep apnea, high cholesterol, etc.)
- Proof you've tried or are doing lifestyle treatment
- Specialist or clinician notes
- Growth-chart history
- A completed prior-authorization form
Your clinician's office usually files the form — ask who does it before you start. (For adults navigating coverage, our roundup of GLP-1 providers that accept Medicare may help, but Medicare is an adult program and isn't a route for a minor.)
How do we talk to our teen about this — without shame?
Keep the focus on health and support, not blame or appearance. Let the clinician handle the medical monitoring, keep your home from turning into a weight-watching zone, and bring your teen into the decision. Kids do better when they feel like a partner, not a project.
Words that help
- "This is one medical option we can talk about — you don't have to decide today."
- "The goal is your health and how you feel, not a number."
- "We'll ask the doctor what's safe, what's not, and what support you'd want."
- "You get a real say in this."
Words to avoid
- "You need this because you can't control yourself."
- "This will fix your body."
- "Everyone's doing it."
- "You'll finally be thin."
If your teen shows any sign of a strained relationship with food or their body, tell the clinician directly. That's not a detour from the conversation — it's the most important part of it.
What if my teen is already 18 — or turns 18 soon?
If the patient is 18 or older, adult GLP-1 telehealth becomes a real option — and the best pick depends on whether they want FDA-approved brand-name medicine, insurance help, or self-pay access.
Best adult (18+) FDA-approved path: Ro
Adults 18+ onlyFor an adult, Ro is a strong, mainstream choice. It carries FDA-approved GLP-1 options — including the Wegovy pen, the new Wegovy pill, Foundayo, Zepbound, Ozempic (off-label when appropriate), and Saxenda — and has a dedicated concierge that verifies benefits and handles prior-authorization paperwork (typically 1–3 weeks). Requires 18 or older.
Ro advertises its Body membership at $39 for the first month, then $149/month, or as low as $74/month with an annual plan paid upfront, plus the cost of medication (verified May 2026).
One honest limitation: Ro says people with government insurance such as Medicare, Medicaid, or TRICARE generally aren't eligible for the program. Check your own situation with Ro before counting on it.
Best for adults who want brand-name medication and help navigating insurance. Not for minors.
For a fuller adult comparison, see our guide to the best GLP-1 telehealth providers and our audit of GLP-1 providers with the best BBB ratings. About the apps that lean on compounded products — Eden, MEDVi, Yucca, SHED — each has an adult niche, but none is a route for a minor, and several aren't built around FDA-approved medicine. Keep them in the adult column.
What should we do next?
If your teen is 12–17, start with a medical evaluation — not an adult checkout page.
- 1Confirm your teen's age and BMI percentile with your pediatrician.
- 2Ask if a referral to a pediatric obesity specialist makes sense.
- 3Ask specifically about the Wegovy injection and Saxenda.
- 4Ask what lifestyle support or non-GLP-1 options to try first or alongside.
- 5Check your insurance coverage and prior-authorization rules.
- 6Verify any online program's age policy before you spend time on it.
- 7Skip compounded shortcuts for a minor unless a pediatric specialist gives a clear reason.
- 8Save the parent checklist and take it to the appointment.
You're not overreacting by asking, and you're not failing your kid by considering medicine. You're doing the careful version of a hard thing — and the careful version starts with the right clinician.
Frequently asked questions
Still deciding where to start?
If you're researching for a 12–17-year-old, start with your pediatrician and the parent checklist above — that's the safe, fast path, and it points to care rather than a sale. If the patient is 18 or older, or you're comparing programs for yourself, you can take our free 60-second matching quiz to see which adult option fits.
Take the free quiz (adults 18+)How this guide was made
By the Weight Loss Provider Guide editorial team. We reviewed FDA drug labels, the FDA's statements on compounded GLP-1s, the AAP's 2023 obesity guideline, and the public terms of major online GLP-1 programs. We ranked care paths by teen eligibility, FDA-approved adolescent medicine, monitoring, insurance support, and compounded-drug risk. We re-verify the facts on this page regularly; the date at the top reflects our last check.
Sources
- Novo Nordisk — FDA approves once-weekly Wegovy for adolescents 12+ (novonordisk-us.com)
- FDA — Wegovy (semaglutide) prescribing information, revised 02/2026 (accessdata.fda.gov)
- Wegovy.com — adolescent indication; the pill is not approved for adolescents
- FDA — Saxenda approval for patients aged 12 and older (fda.gov)
- Novo Nordisk / DailyMed — Saxenda label (adolescents 12+ over 60 kg) (dailymed.nlm.nih.gov)
- Eli Lilly — Open letter: Mounjaro/Zepbound not approved under age 18
- Eli Lilly — FDA approves Foundayo (orforglipron) for adults
- FDA — Foundayo prescribing information (pediatric not established) (accessdata.fda.gov)
- AAP — Executive Summary, 2023 Clinical Practice Guideline (offer pharmacotherapy to ages 12+)
- FDA — Concerns with unapproved GLP-1 drugs used for weight loss (fda.gov)
- FDA — Compounder policy update as GLP-1 supply stabilizes (fda.gov)
- FDA — Warns 30 telehealth companies over compounded GLP-1 marketing (March 3, 2026)
- Novo Nordisk (novoMEDLINK) — pediatric gallbladder event rates for Wegovy
- Ro — GLP-1 / Body Program details and insurance concierge (ro.co)
- Ro — Terms of Use (18+)
- Sesame — Terms of Service (18+)
- Eden — Terms of Service (18+)
- MEDVi — Terms & Conditions (18+)
- Yucca Health — Terms of Service (18+; dispenses compounded medications)
- Walgreens — Virtual weight-loss care (adults 18+; under 18 must see a provider)